Detalles de la búsqueda
1.
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis.
Ann Rheum Dis
; 82(7): 920-926, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37019614
2.
Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: international development of a glucocorticoid treatment-specific patient-reported outcome measure.
Rheumatology (Oxford)
; 62(11): 3565-3575, 2023 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36840642
3.
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective.
J Arthroplasty
; 38(11): 2193-2201, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37778918
4.
Immune Checkpoint Inhibitor-Associated Myositis: A Distinct Form of Inflammatory Myopathy.
J Clin Rheumatol
; 28(7): 367-373, 2022 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35696731
5.
Autoantibodies in Patients With Immune-Related Adverse Events From Checkpoint Inhibitors: A Systematic Literature Review.
J Clin Rheumatol
; 28(2): e498-e505, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34371516
6.
Checkpoint Inhibitor-Associated Arthritis: A Systematic Review of Case Reports and Case Series.
J Clin Rheumatol
; 27(8): e317-e322, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32345841
7.
The Patients' Perspective of Important Glucocorticoid Effects: A Nominal Group Study Among Patients With Systemic Lupus Erythematosus and Myositis.
J Clin Rheumatol
; 27(6): 232-238, 2021 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31985721
8.
Erratum to "2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective" [The Journal of Arthroplasty 38 (2023) 2193-2201].
J Arthroplasty
; 39(3): 851-852, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38049357
9.
Checkpoint Inhibitor-Associated Autoimmunity: What a Rheumatologist Needs to Know.
J Clin Rheumatol
; 28(2): e659-e666, 2022 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31743272
10.
The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis: A Scoping Review.
Rheum Dis Clin North Am
; 50(2): 325-335, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38670730
11.
Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellows.
Semin Arthritis Rheum
; 65: 152391, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38340612
12.
A Review of Spasticity Treatments: Pharmacological and Interventional Approaches.
Crit Rev Phys Rehabil Med
; 25(1-2): 11-22, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-25750484
13.
Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 'shared epitope' are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in longstanding rheumatoid arthritis.
RMD Open
; 9(2)2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37355249
14.
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group.
Semin Arthritis Rheum
; 58: 152110, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36372016
15.
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective.
Arthritis Care Res (Hoboken)
; 75(11): 2227-2238, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37743767
16.
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective.
Arthritis Rheumatol
; 75(11): 1877-1888, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37746897
17.
Rheumatic Complications of Immune Checkpoint Inhibitors.
Rheum Dis Clin North Am
; 48(2): 411-428, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35400368
18.
Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition.
J Immunother Cancer
; 10(1)2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35091456
19.
Rheumatic Complications of Immune Checkpoint Inhibitors.
Med Clin North Am
; 105(2): 227-245, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33589099
20.
Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set.
Semin Arthritis Rheum
; 51(5): 1139-1145, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34253398